Investors / Japan / UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners
Venture capital · Tokyo, Japan · Asia Pacific
UTEC is a venture capital firm that has raised about 130 billion yen across six funds, mainly from institutional investors, and has invested in 160 startups. It works with universities and research institutions in Japan and abroad, investing mainly at the seed stage and taking lead positions with board participation.
Invests inHealthcare & BiotechFintechIndustrial & Manufacturing
In its own wordsscience and technologydeep techseed stageuniversity spinoutsglobal markets
Your fit with UTEC - The University of Tokyo Edge Capital Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsUTEC - The University of Tokyo Edge Capital Partners lists 8 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (36%), Fintech (18%) and Industrial & Manufacturing (18%). 57% of its companies are based in United States. It invests most often alongside B Capital, Berkeley Catalyst Fund and Beyond Next Ventures.
No funding round on record names UTEC - The University of Tokyo Edge Capital Partners yet, so the figures come from its portfolio page.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 15th | 8 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 67th | 36% in its largest sector |
| Reach | 69th | 4 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers8100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 36% | 15% |
| Fintech | 18% | 12% |
| Industrial & Manufacturing | 18% | 7% |
| Robotics & Hardware | 9% | 1% |
| AI & Machine Learning | 9% | 18% |
| Consumer | 9% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare UTEC - The University of Tokyo Edge Capital Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
8 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Amadeus Capital Partners invests in deep tech companies from seed to growth across three technology areas | FintechHealthcare & Biotech | Portfolio page | ||
| Enterasense Limited develops medical devices for diagnosing and monitoring upper gastrointestinal bleeding. | Healthcare & Biotech | Portfolio page | ||
| The company develops and provides AI vision systems for 3D picking and vision-guided robotics | Robotics & Hardware | Portfolio page | ||
| MediciNova is a biopharmaceutical company that is developing novel therapeutics with a primary focus on neurology, respiratory, and liver diseases with unmet medical needs. | Healthcare & Biotech | Portfolio page | ||
| Nelumbo is a materials technology company with products spanning from refrigeration systems to textiles. | Industrial & ManufacturingConsumer | Portfolio page | ||
| Nordstar offers strategic capital and operational expertise to founders of businesses embarking on their next stage of growth. | FintechAI & Machine Learning | Portfolio page | ||
| Red Arrow Therapeutics develops novel therapies for cancer patients using a proprietary nanopolymer drug-delivery system | Healthcare & Biotech | Portfolio page | ||
| The company regenerates metal scrap into high-purity feedstock briquettes for foundries and manufacturers. | Industrial & Manufacturing | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- ut-ec.co.jp
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 8
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get UTEC - The University of Tokyo Edge Capital Partners' profile as data
Pull UTEC - The University of Tokyo Edge Capital Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/ut-ec.co.jp
# also
GET /v1/firms/ut-ec.co.jp/portfolio
GET /v1/firms/ut-ec.co.jp/coinvestors
GET /v1/firms/ut-ec.co.jp/news